Data / New clinical trials / Hungary
New clinical trials in Hungary: 461 since Nov 2024
The full list. New clinical trials with a site in Hungary: 461 rows for $23.05, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 11 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/hungary, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
461 clinical studies with a site in Hungary were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 325 have an industry sponsor and 319 are recruiting or about to. The newest, NCT07926971, was posted on November 9, 2026: Telerehabilitation Hand Training for Patients With Neuromuscular Conditions (University of Pecs).
The request: Every new clinical trial with a site in Hungary, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 461New trials
- 325Industry sponsored
- 319Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 461, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07926971 | Telerehabilitation Hand Training for Patients With Neuromuscular Conditions | University of Pecs | Not applicable | Completed | Myotonic Dystrophy | 14 | Hungary | clinicaltrials.gov |
| November 6, 2026 | NCT07920887 | A Study of Bimagrumab in Participants With HFpEF | Eli Lilly and Company | Phase 2 | Not yet recruiting | Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction, Heart Failure, Preserved... | 540 | Hungary, Italy, Poland, United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany... | clinicaltrials.gov |
| November 4, 2026 | NCT07916688 | Lactic Acid Bacteria in Functional Diarrheal Disorders | Szeged University | Not applicable | Recruiting | IBS-D (Diarrhea-predominant), IBS (Irritable Bowel Syndrome), Functional Diarrhea | 100 | Hungary | clinicaltrials.gov |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia... | clinicaltrials.gov |
| October 30, 2026 | NCT07907705 | Arterial Stiffness During Negative Pressure Wound Therapy for Abdominal Wall Wounds | Dávid Ágoston Kovács | Observational | Not yet recruiting | Postoperative Abdominal Wall Wound Complications, Surgical Wound Infection, Surgical Wound Dehiscence, Mesh-Associated... | 30 | Hungary | clinicaltrials.gov |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary... | clinicaltrials.gov |
| October 26, 2026 | NCT07896174 | Resistance vs Aerobic Prehabilitation Before Colorectal Cancer Surgery | Semmelweis University | Not applicable | Recruiting | Colorectal Cancer, Colorectal Neoplasms, Postoperative Complications | 480 | Hungary | clinicaltrials.gov |
| October 21, 2026 | NCT07885618 | Factors Influencing Outcomes in ECMO and Impella Patients: Metabolic and Thyroid Hormone Dynamics | Gottsegen National Cardiovascular Institute | Observational | Recruiting | Cardiogenic Shock, Euthyroid Sick Syndrome, Critical Illness | 160 | Hungary | clinicaltrials.gov |
| October 14, 2026 | NCT07873593 | The Effects of Protocolized Breathing Exercises on Pulmonary Function in Adolescents With Cerebral Palsy. | Semmelweis University | Not applicable | Not yet recruiting | Cerebral Palsy | 360 | Hungary | clinicaltrials.gov |
| October 13, 2026 | NCT07870824 | A Study to Investigate the Effect of Probiotics (Limosilactobacillus Reuteri DSM 17938 and Limosilactobacillus Reuteri DSM 33633) on... | Milosevits Gergely | Not applicable | Recruiting | Virus Diseases in Children | 194 | Hungary | clinicaltrials.gov |
| October 9, 2026 | NCT07868094 | Deep Neuromuscular Block With Pipecuronium in Patients Undergoing Robotic Thoracic Surgery | University of Debrecen | Observational | Completed | Patients Undergoing General Anesthesia | 19 | Hungary | clinicaltrials.gov |
| September 29, 2026 | NCT07845487 | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Palisade Bio | Phase 2 | Recruiting | Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | 204 | Canada, Czechia, France, Georgia, Hungary, Italy, Latvia, Poland, Romania... | clinicaltrials.gov |
| September 21, 2026 | NCT07831564 | Professional Oral Care and Staff Education in Critically Ill Patients | Semmelweis University | Not applicable | Completed | Critically Ill, Oral Health Care, Critical Illness, Oral Care Performance | 161 | Hungary | clinicaltrials.gov |
| September 18, 2026 | NCT07828041 | Evaluation of the Effects of Orthognathic Surgeries on the Temporomandibular Joint Using a Mandibular Movement Analyzer Device | Semmelweis University | Observational | Recruiting | TMD/Orofacial Pain, Malocclusions | 50 | Hungary | clinicaltrials.gov |
| September 17, 2026 | NCT07825805 | Hand Position, CPR Quality and Rescuer Comfort | University of Pecs | Not applicable | Recruiting | Cardiac Arrest (CA) | 100 | Hungary | clinicaltrials.gov |
| September 17, 2026 | NCT07824921 | The Role Oral Microbiome in the Development and Progression of Aorta Aneurysm and Carotid Atherosclerosis | Semmelweis University | Observational | Enrolling by invitation | Aorta Aneurysm, Carotid Arteriosclerosis | 100 | Hungary | clinicaltrials.gov |
| September 9, 2026 | NCT07810920 | Artificial Intelligence Into Ultrasound Diagnostics in Reproductive Medicine | Semmelweis University | Observational | Recruiting | Endometriosis, Adenomyosis of Uterus, Leiomyoma (Uterine Fibroids), Uterine Neoplasms, Congenital Abnormalities... | 1,600 | Hungary | clinicaltrials.gov |
| September 2, 2026 | NCT07799103 | The Impact of Exercise Intervention on Biological and Functional Aging Through the Lens of Epigenetic Clocks | Hungarian University of Sports Science | Not applicable | Completed | Age Over 50 Years | 74 | Hungary | clinicaltrials.gov |
| August 27, 2026 | NCT07789015 | A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Idiopathic Inflammatory Myopathies | 270 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia... | clinicaltrials.gov |
| August 26, 2026 | NCT07788183 | Gamification in Asynchronous Faculty Development | University of Pecs | Not applicable | Completed | Medical Education, Faculty Development | 73 | Hungary | clinicaltrials.gov |
| August 25, 2026 | NCT07784270 | A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight | AstraZeneca | Phase 3 | Recruiting | Obesity or Overweight, Diabetes Mellitus, Type 2 | 1,500 | Argentina, Australia, Canada, Chile, China, Germany, Hungary, India, Japan... | clinicaltrials.gov |
| August 24, 2026 | NCT07782216 | Critical Hyperacute Assessment Research On Neurobiomarker Kinetics in Acute Brain Injury | University of Pecs | Observational | Recruiting | Brain Injuries, Traumatic, Brain Injuries, Acute, Hypoxia, Brain, Cardiac Arrest (CA) | 477 | Hungary | clinicaltrials.gov |
| August 19, 2026 | NCT07772518 | Intracardiac Echocardiography-guided Versus Electroanatomical Mapping-guided Pulsed Field Ablation for Paroxysmal Atrial Fibrillation | Mitera Hospital | Not applicable | Recruiting | Paroxysmal Atrial Fibrillation (PAF) | 292 | Croatia, Czechia, Greece, Hungary, Italy, Poland, Slovakia, Slovenia | clinicaltrials.gov |
| August 18, 2026 | NCT07771465 | A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy | Kardigan, Inc. | Phase 3 | Recruiting | Symptomatic Genetic Dilated Cardiomyopathy (DCM) | 332 | Belgium, Denmark, France, Hungary, Italy, Netherlands, Poland, Spain, Sweden... | clinicaltrials.gov |
| August 17, 2026 | NCT07768189 | A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma | Corbus Pharmaceuticals Inc. | Phase 3 | Recruiting | Oropharyngeal Carcinoma (OPC) | 260 | Austria, Belgium, Canada, France, Germany, Hungary, Italy, Portugal, Romania... | clinicaltrials.gov |
| August 14, 2026 | NCT07765355 | Virtual Nature Versus Guided Imagery for Anxiety and Well-Being in Hospitalized Older Adults | Semmelweis University | Not applicable | Recruiting | Anxiety, Hospitalization, Quality of Life, Psychological Distress, Depression | 60 | Hungary | clinicaltrials.gov |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Czechia... | clinicaltrials.gov |
| August 12, 2026 | NCT07759245 | A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) | Eli Lilly and Company | Phase 2 | Recruiting | Pulmonary Disease, Chronic Obstructive | 606 | Argentina, Austria, Canada, China, Czechia, Denmark, France, Germany, Hungary... | clinicaltrials.gov |
| August 10, 2026 | NCT07755579 | Effect of Autologous Ear Cartilage Micrografting in Knee Osteoarthritis | Regenera Activa Worldwide S.L. | Not applicable | Active not recruiting | Osteoarthritis, Osteoarthritis (OA) of the Knee, Moderate Osteoarthritis | 33 | Hungary | clinicaltrials.gov |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark... | clinicaltrials.gov |
| August 7, 2026 | NCT07752771 | Durability of Pulmonary Vein Isolation With Farapulse System Using Minimal Fluoroscopy | Semmelweis University | Not applicable | Completed | Atrial Fibrillation (AF), Pulsed-field Ablation | 20 | Hungary | clinicaltrials.gov |
| August 7, 2026 | NCT07752238 | Diagnostic Prediction Model for De Novo Metastatic Breast Cancer | Markusovszky University Teaching Hospital os County Vas | Observational | Recruiting | Breast Cancer, Metastatic Invasive Breast Cancer | 925 | Hungary | clinicaltrials.gov |
| August 6, 2026 | NCT07750405 | A Comparative Study of the Next-Generation TetraGraph® and Mechanomyography Neuromuscular Monitors in Clinical Settings | University of Debrecen | Observational | Not yet recruiting | Patients Undergoing General Anesthesia | 20 | Hungary | clinicaltrials.gov |
| August 5, 2026 | NCT07746583 | A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice | Janssen-Cilag Kft. | Observational | Recruiting | Psoriasis | 100 | Hungary | clinicaltrials.gov |
| August 4, 2026 | NCT07745504 | A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight | Novo Nordisk A/S | Phase 3 | Recruiting | Overweight, Obesity | 285 | Greece, Hungary, Portugal, Serbia, Sweden, United States | clinicaltrials.gov |
| August 3, 2026 | NCT07743021 | Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data | Center for Molecular Fingerprinting Research Nonprofit LLC | Observational | Recruiting | Non-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC), Cardiovascular Diseases (CVD), Atherosclerotic... | 15,000 | Hungary | clinicaltrials.gov |
| August 3, 2026 | NCT07742735 | A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome... | VectivBio AG | Phase 3 | Recruiting | Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF) | 124 | Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark... | clinicaltrials.gov |
| July 30, 2026 | NCT07737743 | A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease | Novartis Pharmaceuticals | Phase 2 | Recruiting | Sjögren's Disease | 344 | Australia, Canada, China, Colombia, France, Hungary, Israel, Netherlands... | clinicaltrials.gov |
| July 29, 2026 | NCT07733687 | Robotic Neurorehabilitation in Patients With Ataxia | Somogy Megyei Kaposi Mór Teaching Hospital | Not applicable | Active not recruiting | Ataxia - Other | 100 | Hungary | clinicaltrials.gov |
| July 29, 2026 | NCT07732855 | Treatment of Ocular Surface Inflammations | Semmelweis University | Observational | Recruiting | Ocular Surface Allergy, Conjunctivitis, Allergic, Blepharoconjunctivitis | 50 | Hungary | clinicaltrials.gov |
| July 28, 2026 | NCT07732205 | Effects of Lokomat-Robot Assisted Gait Training on Gross Motor Function in Children and Young Adults With Cerebral Palsy | Semmelweis University | Not applicable | Not yet recruiting | Cerebral Palsy | 96 | Hungary | clinicaltrials.gov |
| July 27, 2026 | NCT07728188 | A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies... | AbbVie | Phase 3 | Not yet recruiting | Relapsed or Refractory Multiple Myeloma | 520 | Australia, Canada, France, Germany, Hungary, Italy, Netherlands, Norway... | clinicaltrials.gov |
| July 20, 2026 | NCT07713108 | Pelvic Floor Muscle Function and Endometriosis-Related Pelvic Pain | University of Pecs | Observational | Recruiting | Endometriosis, Chronic Pelvic Pain, Pelvic Pain Associated With Endometriosis or Adenomyosis | 100 | Hungary | clinicaltrials.gov |
| July 17, 2026 | NCT07712549 | Interactive Nature-Based Virtual Reality to Reduce Anxiety, Low Mood, and Feelings of Helplessness in Hospitalized Older Adults With... | Moholy-Nagy University of Art and Design | Not applicable | Not yet recruiting | Psychological Distress, Chronic Disease, Learned Helplessness | 100 | Hungary | clinicaltrials.gov |
| July 17, 2026 | NCT07711197 | Effects of Hemoadsorption on Vascular Integrity in Septic Shock | Semmelweis University | Not applicable | Not yet recruiting | Septic Shock | 110 | Hungary | clinicaltrials.gov |
| July 17, 2026 | NCT07711002 | Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy... | AstraZeneca | Phase 3 | Recruiting | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | 1,330 | Austria, Brazil, Canada, China, France, Germany, Hong Kong, Hungary, India... | clinicaltrials.gov |
| July 16, 2026 | NCT07708493 | A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight | Boehringer Ingelheim | Phase 1 | Completed | Healthy | 8 | Hungary | clinicaltrials.gov |
| July 13, 2026 | NCT07698977 | Inhibition of Myopia Progression With Optical Devices | Semmelweis University | Observational | Recruiting | Myopia Progression, Myopia, Myopia, Child Myopia Progression | 50 | Hungary | clinicaltrials.gov |
| July 8, 2026 | NCT07689331 | Hungarian National Systemic Amyloidosis Registry | Semmelweis University | Observational | Recruiting | Systemic Amyloidosis, ATTR Amyloidosis, AL Amyloidosis, Amyloid Cardiomyopathy | 300 | Hungary | clinicaltrials.gov |
| July 6, 2026 | NCT07684547 | REstoration of SYNChronous Cardiac Function Due to Physiologic cArdiac Pacing Modalities With Clinical Endpoints | University of Pecs | Observational | Not yet recruiting | Heart Failure - NYHA II - IV, Left Bundle Branch Area Pacing, Left Bundle Branch Block, Intraventricular Conduction... | 50 | Hungary | clinicaltrials.gov |
| July 1, 2026 | NCT07679555 | Hemodynamic, Laboratory, and Clinical Outcomes of Hemoadsorption Therapy | Pest County Flór Ferenc Hospital | Observational | Recruiting | Hemoadsorption, Vasopressor Therapy | 60 | Hungary | clinicaltrials.gov |
| June 30, 2026 | NCT07675369 | Nationwide Survey of Telemedicinal Patient Education in IBD | Szeged University | Not applicable | Completed | IBD (Inflammatory Bowel Disease) | 432 | Hungary | clinicaltrials.gov |
| June 25, 2026 | NCT07669181 | Examination of the Role of Human Exoskeletons in Rehabilitation | University of Pecs | Not applicable | Active not recruiting | Spinal Cord Injury | 50 | Hungary | clinicaltrials.gov |
| June 25, 2026 | NCT07668388 | A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes | Novo Nordisk A/S | Phase 2 | Recruiting | Diabetes Mellitus, Type 2 | 300 | Australia, Germany, Hungary, Poland, Romania, Slovakia, South Korea, Spain... | clinicaltrials.gov |
| June 25, 2026 | NCT07667933 | Evaluation of Palatal Rugae-Based Identification After Maxillary Expansion Using Local Morphological Patch Analysis | Semmelweis University | Not applicable | Completed | Maxillary Expansion, Forensic Dentistry, Intraoral Scanner, Orthodontic Appliance, Orthognathic Surgical Procedures | 45 | Hungary | clinicaltrials.gov |
| June 24, 2026 | NCT07667023 | Virtual Reality Headset as an Alternative Tool for Reducing Dental Anxiety | Semmelweis University | Not applicable | Enrolling by invitation | Neurodevelopmental Disorder (Diagnosis) | 200 | Hungary | clinicaltrials.gov |
| June 24, 2026 | NCT07666724 | Oncology Treatment Related Ocular Surface Changes | Semmelweis University | Observational | Completed | Breast Neoplasm, Exercise | 35 | Hungary | clinicaltrials.gov |
| June 23, 2026 | NCT07662213 | A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 1,200 | Argentina, Australia, Brazil, Bulgaria, Canada, China, Germany, Hungary, Italy... | clinicaltrials.gov |
| June 23, 2026 | NCT07662109 | A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 2,000 | Argentina, Brazil, China, Czechia, Denmark, Germany, Greece, Hungary, India... | clinicaltrials.gov |
| June 23, 2026 | NCT07662044 | A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 800 | Argentina, China, Denmark, Greece, Hungary, Japan, Slovakia, South Africa... | clinicaltrials.gov |
| June 17, 2026 | NCT07652658 | A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | AstraZeneca | Phase 2 | Recruiting | Idiopathic Pulmonary Fibrosis (IPF) | 359 | Argentina, Australia, Bulgaria, Canada, Chile, China, Denmark, France, Germany... | clinicaltrials.gov |
| June 17, 2026 | NCT07652294 | Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD | Spyre Therapeutics, Inc. | Phase 2 | Enrolling by invitation | Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative | 645 | Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Georgia... | clinicaltrials.gov |
| June 12, 2026 | NCT07644429 | Biomechanical Characterisation of 3D Printed Comfort Insoles | University of Pecs | Not applicable | Active not recruiting | Healthy | 100 | Hungary | clinicaltrials.gov |
| June 5, 2026 | NCT07630974 | A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) | Merck Sharp & Dohme LLC | Phase 1/2 | Recruiting | Malignant Neoplasm | 134 | Australia, Belgium, Czechia, Denmark, France, Hungary, Israel, Netherlands... | clinicaltrials.gov |
| June 5, 2026 | NCT07628556 | Antidiabetic Medications and Risk of Cancer | University of Pecs | Observational | Completed | Cancer | 74,799 | Hungary | clinicaltrials.gov |
| June 4, 2026 | NCT07625644 | BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01) | SystImmune Inc. | Phase 3 | Recruiting | Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc, SCLC,Extensive Stage, Lung... | 550 | Australia, Bulgaria, Canada, Czechia, France, Georgia, Germany, Greece... | clinicaltrials.gov |
| June 4, 2026 | NCT07625215 | A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation | Bayer | Phase 2 | Recruiting | Atrial Fibrillation | 360 | Belgium, Bulgaria, Germany, Hungary, Italy, Netherlands, Poland, United States | clinicaltrials.gov |
| June 3, 2026 | NCT07623200 | A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia | Incyte Corporation | Phase 3 | Recruiting | Essential Thrombocythemia | 426 | Australia, Austria, Belgium, Canada, Czechia, France, Georgia, Germany... | clinicaltrials.gov |
| June 3, 2026 | NCT07623161 | A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib | Takeda | Phase 3 | Recruiting | Myelofibrosis, Anemia | 324 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile... | clinicaltrials.gov |
| June 2, 2026 | NCT07621809 | Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease... | Novartis Pharmaceuticals | Phase 3 | Recruiting | Sjögren´s Disease | 570 | Australia, Austria, Brazil, Canada, China, Colombia, Czechia, France, Germany... | clinicaltrials.gov |
| June 1, 2026 | NCT07619131 | A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in... | AstraZeneca | Phase 3 | Recruiting | Hypercholesterolaemia | 600 | Bulgaria, Canada, Denmark, Germany, Hungary, Israel, Poland, Spain, Ukraine... | clinicaltrials.gov |
| May 29, 2026 | NCT07614776 | A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular... | Amgen | Phase 3 | Recruiting | Neovascular Age-related Macular Degeneration, nAMD | 304 | Czechia, Hungary, Japan, Latvia, Lithuania, Poland, Slovakia, Spain, United... | clinicaltrials.gov |
| May 29, 2026 | NCT07613294 | A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High... | Eli Lilly and Company | Phase 3 | Recruiting | Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a) | 252 | Australia, Czechia, Hungary, Netherlands, Spain, United Kingdom, United States | clinicaltrials.gov |
| May 27, 2026 | NCT07608822 | BIO|STREAM.CSP CLS | Biotronik SE & Co. KG | Observational | Recruiting | Sinus Node Disease, Atrioventricular Block | 150 | Czechia, Hungary, Italy, Portugal, Spain | clinicaltrials.gov |
| May 26, 2026 | NCT07606066 | A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes... | AstraZeneca | Observational | Recruiting | Type 2 Diabetes | 2,150 | Brazil, Hungary, India, Malaysia, Poland, Turkey (Türkiye), United States | clinicaltrials.gov |
| May 22, 2026 | NCT07604519 | Multi-Ingredient Supplementation in Professional Football Players | Vizja University in Warsaw | Not applicable | Completed | Sports Performance, Cognitive Performance During Physical Activity, Fatigue, Recovery, Football Players | 97 | Hungary, Poland, Spain | clinicaltrials.gov |
| May 20, 2026 | NCT07599878 | Adjunctive Group Psychotherapy for Moderate-to-Severe Atopic Dermatitis: A Pilot Feasibility Study Comparing Two Interventions | Semmelweis University | Not applicable | Completed | Atopic Dermatitis | 32 | Hungary | clinicaltrials.gov |
| May 20, 2026 | NCT07599813 | A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis | Apollo Therapeutics Ltd | Phase 2 | Recruiting | Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic, Dermatologic Disease, Eczema, Eczema Atopic Dermatitis... | 280 | Bulgaria, Canada, Czechia, Germany, Hungary, Poland, Spain, United States | clinicaltrials.gov |
| May 20, 2026 | NCT07598825 | A Trial of Inebilizumab in Participants With Autoimmune Hepatitis | Amgen | Phase 3 | Recruiting | Autoimmune Hepatitis, AIH | 180 | Belgium, Canada, China, France, Germany, Hungary, Italy, United States | clinicaltrials.gov |
| May 19, 2026 | NCT07595419 | Treatment of de Quervain's Tendinopathy With Eccentric Training Program | Dr. Lenti Katalin | Not applicable | Completed | de Quervain's Tenosynovitis | 25 | Hungary | clinicaltrials.gov |
| May 18, 2026 | NCT07594080 | Biomarkers of Environment Sensitivity | Semmelweis University | Not applicable | Active not recruiting | Stress, Mental Health and General Well-being | 125 | Hungary | clinicaltrials.gov |
| May 15, 2026 | NCT07589634 | A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants... | Janssen Research & Development, LLC | Phase 2 | Recruiting | Multiple Myeloma | 230 | Argentina, Australia, France, Greece, Hungary, Malaysia, Portugal, Spain... | clinicaltrials.gov |
| May 14, 2026 | NCT07587866 | Panuri Performance Study | Urteste S.A | Observational | Recruiting | Pancreatic Ductal Adenocarcinoma (PDAC) | 1,100 | Hungary, Italy, Poland | clinicaltrials.gov |
| May 11, 2026 | NCT07577856 | A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis | Janssen Research & Development, LLC | Phase 3 | Recruiting | Colitis, Ulcerative | 644 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China... | clinicaltrials.gov |
| May 11, 2026 | NCT07577843 | A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohn Disease | 460 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France... | clinicaltrials.gov |
| May 7, 2026 | NCT07573462 | A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants | Pfizer | Phase 3 | Recruiting | Pneumococcal Disease | 2,400 | Argentina, Australia, Canada, Finland, Germany, Greece, Hungary, Italy, Poland... | clinicaltrials.gov |
| May 6, 2026 | NCT07571395 | Median Nerve Electromyography to Monitor Intraoperative Neuromuscular Function | Pongrácz Adrienn | Observational | Recruiting | Nerve Conduction Study, Elective Surgery, Neuromuscular Monitoring After Administration of Neuromuscular Blocking... | 45 | Hungary | clinicaltrials.gov |
| May 4, 2026 | NCT07564414 | A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or... | Novo Nordisk A/S | Phase 3 | Recruiting | Obesity, Type 2 Diabetes | 2,500 | Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France... | clinicaltrials.gov |
| May 1, 2026 | NCT07562152 | Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma | Immuneering Corporation | Phase 3 | Recruiting | Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal... | 570 | Australia, Georgia, Germany, Hungary, Poland, Romania, Spain, United Kingdom... | clinicaltrials.gov |
| April 30, 2026 | NCT07559175 | A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency. | Aimmune Nestlé Health Science US R&D, LLC | Phase 2 | Recruiting | Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality, Pancreatic Diseases | 66 | Bulgaria, Hungary, Italy, Poland, Spain, United Kingdom, United States | clinicaltrials.gov |
| April 28, 2026 | NCT07554495 | Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis... | Alfasigma S.p.A. | Phase 3 | Recruiting | Polyarticular Course Juvenile Idiopathic Arthritis | 65 | Belgium, Czechia, France, Germany, Hungary, Italy, Poland, Spain, United Kingdom | clinicaltrials.gov |
| April 16, 2026 | NCT07533175 | AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose... | Novo Nordisk A/S | Phase 3 | Active not recruiting | Diabetes Mellitus, Overweight, Obesity | 638 | Argentina, Brazil, Croatia, Hungary, Italy, Mexico, Romania, Slovakia, South... | clinicaltrials.gov |
| April 16, 2026 | NCT07532772 | Transfusion Practices in Intensive Care Units: a Hungarian Nationwide Survey | Pest County Flór Ferenc Hospital | Observational | Completed | Central Venous Oxygen Saturation, Anaemia, Lactate, Transfusion, Questionnaire and Survey | 97 | Hungary | clinicaltrials.gov |
| April 13, 2026 | NCT07525375 | A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in... | AstraZeneca | Phase 2 | Recruiting | Asthma | 69 | Argentina, Czechia, Hungary, Mexico, Poland, Serbia, United States | clinicaltrials.gov |
| April 13, 2026 | NCT07523022 | Comparison of the Effect of Gonadotropin and Clomiphene Citrate Treatment on Sperm Parameters and the Outcome of Assisted Reproductive... | Szeged University | Phase 4 | Enrolling by invitation | Male Infertility | 500 | Hungary | clinicaltrials.gov |
| April 9, 2026 | NCT07520877 | Effect of AED-optimized Telephone-assisted CPR Instructions on No-flow Time and Chest Compression Fraction | University of Pecs | Not applicable | Completed | Cardiac Arrest (CA) | 100 | Hungary | clinicaltrials.gov |
| April 9, 2026 | NCT07519902 | An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED | Dompé Farmaceutici S.p.A | Phase 3 | Recruiting | Persistent Corneal Epithelial Defect | 150 | Argentina, Czechia, France, Germany, Hungary, Italy, Japan, Mexico... | clinicaltrials.gov |
| April 9, 2026 | NCT07519382 | Comparing the Clinical Success of Two Different CAD/CAM Full Cuspal Coverage Onlays | Semmelweis University | Not applicable | Enrolling by invitation | Tooth Decay | 164 | Hungary | clinicaltrials.gov |
| April 8, 2026 | NCT07517315 | Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to... | Sun Pharma Advanced Research Company Limited | Not applicable | Temporarily not available | CML, Relapsed, CML, Refractory | Not listed | France, Hungary, India, Italy, Romania, Spain, United States | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Semmelweis University | 51 | October 26, 2026 |
| AstraZeneca | 29 | August 25, 2026 |
| University of Pecs | 21 | November 9, 2026 |
| Merck Sharp & Dohme LLC | 21 | June 5, 2026 |
| Eli Lilly and Company | 20 | November 6, 2026 |
| Sanofi | 19 | February 20, 2026 |
| Janssen Research & Development, LLC | 16 | May 15, 2026 |
| Novartis Pharmaceuticals | 14 | July 30, 2026 |
| Boehringer Ingelheim | 13 | November 4, 2026 |
| Pfizer | 11 | May 7, 2026 |
| Novo Nordisk A/S | 10 | November 5, 2026 |
| Szeged University | 10 | November 4, 2026 |
| Amgen | 10 | May 29, 2026 |
| Bristol-Myers Squibb | 10 | January 23, 2026 |
| Hoffmann-La Roche | 9 | February 18, 2026 |
| AbbVie | 7 | July 27, 2026 |
| Takeda | 6 | June 3, 2026 |
| Tamas Vegh, MD | 6 | January 9, 2026 |
| Immunovant Sciences GmbH | 6 | December 16, 2025 |
| Somogy Megyei Kaposi Mór Teaching Hospital | 5 | July 29, 2026 |
Conditions
| Condition group | New trials | Latest |
|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 20 | August 3, 2026 |
| Obesity | 19 | November 5, 2026 |
| Diabetes Mellitus, Type 2 | 17 | October 28, 2026 |
| Overweight | 15 | October 28, 2026 |
| Colitis, Ulcerative | 15 | September 29, 2026 |
| Lung Neoplasms | 13 | August 3, 2026 |
| Heart Failure | 11 | August 12, 2026 |
| Pulmonary Disease, Chronic Obstructive | 10 | August 12, 2026 |
| Breast Neoplasms | 9 | August 7, 2026 |
| Neoplasms | 9 | August 3, 2026 |
| Dermatitis, Atopic | 9 | May 20, 2026 |
| Crohn Disease | 9 | May 11, 2026 |
| Cardiovascular Diseases | 8 | October 28, 2026 |
| Stroke | 8 | August 3, 2026 |
| Neoplasm Metastasis | 8 | May 1, 2026 |
| Atherosclerosis | 7 | August 3, 2026 |
| Hidradenitis Suppurativa | 7 | February 3, 2026 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 7 | October 14, 2025 |
| Hypertension | 6 | November 5, 2026 |
| Lung Diseases | 6 | August 12, 2026 |
| Renal Insufficiency, Chronic | 6 | August 10, 2026 |
| Small Cell Lung Carcinoma | 6 | June 4, 2026 |
| Asthma | 6 | April 13, 2026 |
| Inflammatory Bowel Diseases | 5 | September 29, 2026 |
| Heart Arrest | 5 | September 17, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Phase 3 | 206 | November 5, 2026 |
| Not applicable | 78 | November 9, 2026 |
| Phase 2 | 75 | November 6, 2026 |
| Observational | 65 | October 30, 2026 |
| Phase 4 | 11 | April 13, 2026 |
| Phase 2/3 | 11 | March 27, 2026 |
| Phase 1 | 8 | July 16, 2026 |
| Phase 1/2 | 5 | June 5, 2026 |
| Early phase 1 | 2 | December 24, 2024 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.